We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NHWK market cap is 10.78M. The company's latest EPS is USD -1.7336 and P/E is -1.37.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 189k | 1.76M | 658k | 723k | 4.85M |
| Operating Income | -15.5M | -13.04M | -13.32M | -8.35M | -6.44M |
| Net Income | -12.15M | -12.79M | -13.89M | -13.13M | -5.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.05M | 2.95M | 2.11M | 9.84M | 7M |
| Operating Income | -20.75M | -24.93M | -34.99M | -45.69M | -42.03M |
| Net Income | -20.02M | -26.05M | -35.07M | -43.44M | -45.22M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 104.4M | 91.52M | 80.18M | 69.92M | 51.04M |
| Total Liabilities | 31.96M | 31.18M | 33.12M | 36.47M | 22.74M |
| Total Equity | 72.44M | 60.34M | 47.07M | 33.45M | 28.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.96M | 124.2M | 120.96M | 104.4M | 51.04M |
| Total Liabilities | 12.8M | 8.7M | 8.93M | 31.96M | 22.74M |
| Total Equity | 13.16M | 115.49M | 112.03M | 72.44M | 28.3M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.7M | -13.79M | -22M | -30.46M | -31.53M |
| Investing | 10.99M | 13.49M | 22.32M | 30.14M | 32.24M |
| Financing | -4.91M | -299k | -2.92M | -2.75M | -8.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.84M | -22.02M | -38.13M | -5.7M | -31.53M |
| Investing | -293k | -95.42M | 9.77M | 10.99M | 32.24M |
| Financing | 19k | 119.33M | 25.49M | -4.91M | -8.95M |
| Market Cap | 10.78M |
| Price to Earnings Ratio | -1.37 |
| Price to Sales Ratio | 8.87 |
| Price to Cash Ratio | 335.21 |
| Price to Book Ratio | 2.19 |
| Dividend Yield | - |
| Shares Outstanding | 26.08M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -35.46% |
| 52 Week High | 0.885 |
| 52 Week Low | 0.258 |
| Spread (Intraday) | 0.03 (6.87%) |
| Company Name | Nighthawk Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ir.scorpiusbiologics.com/ |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
